Low Pretreatment Albumin-to-Globulin Ratios Predict Poor Survival Outcomes in Patients with Head and Neck Cancer: A Systematic Review and Meta-analysis
Yunting Wang, Liang‐Tseng Kuo, Chia‐Hsuan Lai, Yuan‐Hsiung Tsai, Yi‐Chan Lee, Cheng‐Ming Hsu, Chun‐Ta Liao, Chung‐Jan Kang, Ethan I. Huang, Ming‐Shao Tsai, Geng‐He Chang, Yao‐Te Tsai
Abstract
AGR can serve as a prognostic biomarker in managing HNC, and a low pretreatment AGR is strongly associated with adverse survival outcomes and advanced cancer status. Additional large-scale prospective trials must be conducted to assess the validity of our findings.
Topics & Concepts
MedicineHazard ratioInternal medicineConfidence intervalMeta-analysisHead and neck cancerOncologyBiomarkerCancerCochrane LibraryGastroenterologyChemistryBiochemistryInflammatory Biomarkers in Disease PrognosisHead and Neck Cancer StudiesBone and Joint Diseases